Reverse shoulder replacement

HSS Interactive Case Lecture Highlights Practical Solutions In Shoulder Arthroplasty For Substantial Glenoid Bone Loss

Retrieved on: 
Friday, September 3, 2021
Surgery, Medical specialties, Medicine, Prosthetics, Hospital for Special Surgery, Orthopedic surgery, Reverse shoulder replacement, Arthroplasty, Knee replacement, Bone grafting, Shoulder, Glenoid fossa

The glenoid is the socket part of the shoulder joint that connects to the ball of the upper arm bone.

Key Points: 
  • The glenoid is the socket part of the shoulder joint that connects to the ball of the upper arm bone.
  • Glenoid bone loss can occur due to severe arthritis, traumatic injury or repetitive overuse in sports like baseball or swimming.
  • Symptoms associated with glenoid bone loss include inflammation, pain and decreased shoulder function.
  • Surgical approaches presented included two bone grafting techniques: bony increased offset-total shoulder arthroplasty (BIO-TSA) and bony increased offset-reverse shoulder arthroplasty (BIO-RSA).

Shoulder Innovations Announces FDA 510(k) Clearance For InSet™ Reverse Shoulder Platform Technology

Retrieved on: 
Monday, August 23, 2021
Education, LLC, Reverse, ASC, Longevity, Convertible, Efficiency, Reverse shoulder replacement, AI, Health, Multimedia, Patient, CEO, FDA, Simple, Technology, Deployable Operations Group, Medical device, Dentistry, Pharmaceutical industry

HOLLAND, Mich., Aug. 23, 2021 /PRNewswire/ -- Shoulder Innovations Inc, a leading innovator in the development of shoulder replacement systems, announced today that they have received FDA clearance for their InSet Reverse Shoulder Arthroplasty System.

Key Points: 
  • HOLLAND, Mich., Aug. 23, 2021 /PRNewswire/ -- Shoulder Innovations Inc, a leading innovator in the development of shoulder replacement systems, announced today that they have received FDA clearance for their InSet Reverse Shoulder Arthroplasty System.
  • David Blue, Chief Commercialization Officer for Shoulder Innovations, said, "Our surgeon customers value having all possible shoulder surgery implants and instruments available in one tray.
  • Matt Ahearn, Chief Operating Officer for Shoulder Innovations, said, "Shoulder Innovations has been preparing for this product release for many months.
  • The FDA clearance and upcoming launch of the InSet Reverse Shoulder represent a significant inflection point for all aspects of the Shoulder Innovations business.

Catalyst OrthoScience Announces First Surgeries Using Archer™ R1 Reverse Shoulder System

Retrieved on: 
Wednesday, May 5, 2021
Biotechnology, Health, Surgery, Medical devices, Arthritis, Reverse shoulder replacement, Orthopedic surgery, Arthroplasty

b"Catalyst OrthoScience Inc. (Catalyst), a medical device company focused on the upper extremity orthopedics market, today announced the first surgeries using the new Archer\xe2\x84\xa2 R1 Reverse Shoulder System.

Key Points: 
  • b"Catalyst OrthoScience Inc. (Catalyst), a medical device company focused on the upper extremity orthopedics market, today announced the first surgeries using the new Archer\xe2\x84\xa2 R1 Reverse Shoulder System.
  • With the introduction of the Archer R1 system, Catalyst is addressing the two fastest growing segments of the shoulder arthroplasty market \xe2\x80\x93 stemless anatomic and reverse TSA.\nThis press release features multimedia.
  • View the full release here: https://www.businesswire.com/news/home/20210505005125/en/\nCatalyst OrthoScience's Archer\xe2\x84\xa2 R1 Reverse Shoulder System offers surgeon-targeted implant positioning, a streamlined and versatile system, and bone sparing implants.
  • team.\xe2\x80\x9d\nCatalyst\xe2\x80\x99s Archer R1 reverse system is a single-tray arthroplasty system that was engineered to combine the most beneficial and evidence-based attributes of reverse shoulder arthroplasty design.

Catalyst OrthoScience Gains Momentum As It Introduces The Archer™ R1 Reverse Shoulder System And Rebrands Its Archer™ CSR Total Shoulder System

Retrieved on: 
Wednesday, April 28, 2021
Biotechnology, FDA, Surgery, Medical devices, Health, Arthritis, Arthroplasty, Reverse shoulder replacement

We feel the Archer product family name represents these tenets well in the market place.\xe2\x80\x9d\nRecently, Catalyst announced 510(k) clearance of the Archer R1 Reverse Shoulder System, expanding its product portfolio with multiple arthroplasty options.

Key Points: 
  • We feel the Archer product family name represents these tenets well in the market place.\xe2\x80\x9d\nRecently, Catalyst announced 510(k) clearance of the Archer R1 Reverse Shoulder System, expanding its product portfolio with multiple arthroplasty options.
  • Catalyst\xe2\x80\x99s reverse shoulder system is a single-tray arthroplasty system that was engineered to combine the most beneficial and evidence-based attributes of reverse shoulder arthroplasty design.
  • Since its introduction in 2016, Catalyst\xe2\x80\x99s Archer CSR system has experienced explosive adoption and growth.
  • The Archer CSR system is unique, offering precision and accuracy in shoulder restoration while preserving the patient\xe2\x80\x99s bone and soft tissue.

LimaCorporate Announces The First Surgery Of SMR Stemless Reverse Shoulder System In The IDE Study

Retrieved on: 
Tuesday, April 20, 2021
Medical specialties, Pharmaceutical industry, Health sciences, Medicine, Arthritis, Investigational device exemption, Arthroplasty, Reverse shoulder replacement, IDE, Clinical trial

b'SAN DANIELE DEL FRIULI,Italy, April 20, 2021 /PRNewswire/ -- LimaCorporate is proud to announce the first surgery performed in the SMR Stemless Reverse Shoulder System Investigational Device Exemption (IDE) study.

Key Points: 
  • b'SAN DANIELE DEL FRIULI,Italy, April 20, 2021 /PRNewswire/ -- LimaCorporate is proud to announce the first surgery performed in the SMR Stemless Reverse Shoulder System Investigational Device Exemption (IDE) study.
  • This randomized, multi-center comparative clinical trial is currently evaluating the safety and effectiveness of the SMR Stemless Reverse Shoulder System compared to the SMR Reverse Shoulder System, in total reverse shoulder arthroplasty.
  • FDA approval of the SMR Stemless Reverse Shoulder System IDE was obtained in November 2020 and patient enrollment began in April 2021.
  • LimaCorporate\'s IDE study on SMR Stemless Reverse System is a pivotal first step to address this unmet need in the U.S. shoulder arthroplasty market.

LimaCorporate Announces The First Surgery Of SMR Stemless Reverse Shoulder System In The IDE Study

Retrieved on: 
Tuesday, April 20, 2021
Medical specialties, Pharmaceutical industry, Health sciences, Medicine, Arthritis, Investigational device exemption, Arthroplasty, Reverse shoulder replacement, IDE, Clinical trial

b'SAN DANIELE DEL FRIULI,Italy, April 20, 2021 /PRNewswire/ -- LimaCorporate is proud to announce the first surgery performed in the SMR Stemless Reverse Shoulder System Investigational Device Exemption (IDE) study.

Key Points: 
  • b'SAN DANIELE DEL FRIULI,Italy, April 20, 2021 /PRNewswire/ -- LimaCorporate is proud to announce the first surgery performed in the SMR Stemless Reverse Shoulder System Investigational Device Exemption (IDE) study.
  • This randomized, multi-center comparative clinical trial is currently evaluating the safety and effectiveness of the SMR Stemless Reverse Shoulder System compared to the SMR Reverse Shoulder System, in total reverse shoulder arthroplasty.
  • FDA approval of the SMR Stemless Reverse Shoulder System IDE was obtained in November 2020 and patient enrollment began in April 2021.
  • LimaCorporate\'s IDE study on SMR Stemless Reverse System is a pivotal first step to address this unmet need in the U.S. shoulder arthroplasty market.

Catalyst OrthoScience Receives FDA 510(k) Clearance of Its Reverse Shoulder System

Retrieved on: 
Wednesday, March 17, 2021
FDA, Health, Medical devices, Medical specialties, Surgery, Clinical medicine, Arthritis, Orthopedic surgery, Arthroplasty, Reverse shoulder replacement, Catalysis, Prosthetics

Catalyst OrthoScience Inc. (Catalyst), a medical device company focused on the upper extremity orthopedics market, has received clearance from the U.S. Food & Drug Administration (FDA) to market its reverse shoulder system.

Key Points: 
  • Catalyst OrthoScience Inc. (Catalyst), a medical device company focused on the upper extremity orthopedics market, has received clearance from the U.S. Food & Drug Administration (FDA) to market its reverse shoulder system.
  • The addition of the reverse shoulder system allows Catalyst to offer a broader shoulder portfolio and multiple arthroplasty options to shoulder surgeons across the U.S.
  • With the addition of our reverse shoulder system, Catalyst is now addressing the two fastest growing segments of the shoulder arthroplasty market stemless anatomic and reverse TSA, said Brian K. Hutchison , chairman and CEO of Catalyst.
  • Catalysts reverse shoulder system is a single-tray arthroplasty system that was engineered to combine the most beneficial and evidence-based attributes of reverse shoulder arthroplasty design.

FX Solutions, SAS. [FX Shoulder, Inc.] Receives FDA 510k Clearances for Humeral Cup Stability & Humeral Cup 135/145° Stability

Retrieved on: 
Friday, May 1, 2020
Medicine, Reverse shoulder replacement, Shoulder replacement, FX, Shoulder, Television

DALLAS, May 1, 2020 /PRNewswire/ --FX received 510k clearances for their Humeral Cup Stability & Humeral Cup 135/145 Stabilityfor reverse shoulder arthroplasty.

Key Points: 
  • DALLAS, May 1, 2020 /PRNewswire/ --FX received 510k clearances for their Humeral Cup Stability & Humeral Cup 135/145 Stabilityfor reverse shoulder arthroplasty.
  • The stability cup will be offered in all three sizes that FX Solutions [FX Shoulder USA, Inc.] have available to the market in 32mm, 36mm, and 40mm.
  • "This is certainly a positive step forward and welcome good news in the current challenging, and unprecedented, times we are experiencing," said Baptiste Martin, CEO of FX Shoulder USA.
  • FX Shoulder USA, Inc. is based in Dallas, TX and is the direct provider of FX Solutions shoulder replacement devices in the U.S. FX Shoulder USA, Inc., founded in January 2018, focuses exclusively on shoulder arthroplasty.For additional information, please visit www.fxshoulder.com .

FX Solutions, SAS. [FX Shoulder, Inc.] Receives FDA 510k Clearances for Glenoid Baseplate With a Central Screw and 32mm Glenosphere and Humeral Cups

Retrieved on: 
Monday, March 2, 2020
Shoulder, Reverse shoulder replacement, Glenoid cavity, FX, Screw, Television, Visual arts

DALLAS, March 2, 2020 /PRNewswire/ --FX received 510k clearances for their Glenoid Baseplate with a Central Screw and 32mm Glenosphere and Humeral Cups for reverse shoulder arthroplasty.

Key Points: 
  • DALLAS, March 2, 2020 /PRNewswire/ --FX received 510k clearances for their Glenoid Baseplate with a Central Screw and 32mm Glenosphere and Humeral Cups for reverse shoulder arthroplasty.
  • The Glenoid Baseplate includes a Central Screw that has (7) different central screw size length options ranging from 8mm to 20mm in 2mm increments.
  • This provides an alternative to the glenoid baseplate having a central post and post extensions that FX currently has available to the US market.
  • The 32mm Glenosphere and Humeral Cups further expand the offerings that FX has available to the US market, which includes the existing sizes of 36mm and 40mm.

Shoulder Replacement Market to Touch Nearly US$ 4 Billion by 2027, Says TMR

Retrieved on: 
Tuesday, June 25, 2019
Surgery, Medical specialties, Medicine, Prosthetics, Arthritis, Shoulder surgery, Surgical specialties, Shoulder replacement, Arthroplasty, Reverse shoulder replacement, Orthopedic surgery

On the basis of geography, Asia Pacific is likely to hold a major share in the global shoulder replacement market.

Key Points: 
  • On the basis of geography, Asia Pacific is likely to hold a major share in the global shoulder replacement market.
  • In terms of surgical procedures, the global shoulder replacement is segmented into total shoulder replacement, partial shoulder replacement, shoulder resurfacing, and revision shoulder replacement.
  • Of these, reverse shoulder replacement is expected to dominate the global shoulder replacement during the forecast year.
  • This review is based on the findings of a TMR report titled, "Shoulder Replacement Market (Procedure: Total Shoulder Replacement, Reverse Shoulder Replacement, Partial Shoulder Replacement, Shoulder Resurfacing, and Revision Shoulder Arthroplasty; End User: Hospitals, Ambulatory Surgical Centers, and Orthopedic Clinics)) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 2027."